Evidence map›Paper›PMID 33454249›Full record

Trial reportJACC. Cardiovascular imaging2021

CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

G B John Mancini, Jonathan Leipsic, Matthew J Budoff, Cameron J Hague, James K Min, Susanna R Stevens, Harmony R Reynolds, Sean M O'Brien, Leslee J Shaw, Cholenahally N Manjunath and 11 more

Erratum issued Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JACC. Cardiovascular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07192965 (ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain), which is not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07192965 narecruitingnot on this mapstarted 2025, after this paper: background citation

ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain

TypeinterventionalSponsorUniversitair Ziekenhuis BrusselRan2025 to 2028Enrolled230ConditionsChest Pain, Acute Coronary Syndromes (ACS)ArmsNon-ECG-gated computed tomography
3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.Journal of the American College of Cardiology · 2022
    Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of cardiac imaging in the post-ISCHEMIA world.The British journal of radiology · 2025
    Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

G B John ManciniCenter for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mancini@mail.ubc.ca.
Jonathan LeipsicCenter for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
Matthew J BudoffLundquist Institute, Torrance, California, USA.
Cameron J HagueCenter for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada; St. Paul's Hospital Department of Radiology, Vancouver, British Columbia, Canada.
James K MinCleerly, Inc., New York, New York, USA.
Susanna R StevensDuke Clinical Research Institute, Durham, North Carolina, USA.
Harmony R ReynoldsNew York University Grossman School of Medicine, New York, New York, USA.
Sean M O'BrienDuke Clinical Research Institute, Durham, North Carolina, USA.
Leslee J ShawWeill Cornell Medicine, New York, New York, USA.
Cholenahally N ManjunathSri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India.
Kreton MavromatisEmory University School of Medicine, Atlanta, Georgia, USA.
Marcin DemkowInstitute of Cardiology, Warsaw, Poland.
Jose Luis Lopez-SendonHospital Universitario La Paz-IdiPaz- CIBER-CV, Madrid, Spain.
Alexander M ChernavskiyE.Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Gilbert GosselinMontréal Heart Institute, Montréal, Québec, Canada.
Herwig SchuchlenzLKH Graz II, Department fuer Kardiologie und Intensivmedizin, Graz, Austria.
Gerard P DevlinGisborne Hospital, Gisborne, New Zealand.
Anoop ChauhanBlackpool Teaching Hospitals, Lancashire, United Kingdom.
Sripal BangaloreNew York University Grossman School of Medicine, New York, New York, USA.
Judith S HochmanNew York University Grossman School of Medicine, New York, New York, USA.
David J MaronDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
The ISCHEMIA Trial - SDCCU01HL105462 · NHLBI · DUKE UNIVERSITY · PI ALEXANDER, KAREN P, O'BRIEN, SEAN M · 2011 to 2019
$17.8M
THE ISCHEMIA TRIAL - IICCU01HL105561 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHAW, LESLEE J · 2011 to 2018
$6.5M
NCATS NIH HHS UL1 TR001445NHLBI NIH HHS U01 HL105462NHLBI NIH HHS U01 HL105561NHLBI NIH HHS U01 HL105907
6 · The paper itself

Abstract

objectivesThis study aimed to examine the concordance of coronary computed tomographic angiography (CCTA) assessment of coronary anatomy and invasive coronary angiography (ICA) as the reference standard in patients enrolled in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches).

backgroundPerformance of CCTA compared with ICA has not been assessed in patients with very high burdens of stress-induced ischemia and a high likelihood of anatomically significant coronary artery disease (CAD). A blinded CCTA was performed after enrollment to exclude patients with left main (LM) disease or no obstructive CAD before randomization to an initial conservative or invasive strategy, the latter guided by ICA and optimal revascularization.

methodsRates of concordance were calculated on a per-patient basis in patients randomized to the invasive strategy. Anatomic significance was defined as ≥50% diameter stenosis (DS) for both modalities. Sensitivity analyses using a threshold of ≥70% DS for CCTA or considering only CCTA images of good-to-excellent quality were performed.

resultsIn 1,728 patients identified by CCTA as having no LM disease ≥50% and at least single-vessel CAD, ICA confirmed 97.1% without LM disease ≥50%, 92.2% with at least single-vessel CAD and no LM disease ≥50%, and only 4.9% without anatomically significant CAD. Results using a ≥70% DS threshold or only CCTA of good-to-excellent quality showed similar overall performance.

conclusionsCCTA before randomization in ISCHEMIA demonstrated high concordance with subsequent ICA for identification of patients with angiographically significant disease without LM disease.

Indexed as

AngiographyComputed Tomography AngiographyHumansIschemiaPredictive Value of Testscardiac catheterizationcardiac computed tomographic angiographyinvasive coronary angiographyischemialeft main coronary artery disease

Identifiers

PMID33454249
PMCPMC8260655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.